Complete Filing Data
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Stockholders Equity of $9.66 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean LIXTE BIOTECHNOLOGY HOLDINGS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.1M | -$3.6M | -$5.1M | -$6.3M | -$6.7M | -$3.3M | -$2.4M | -$2.1M | -$1.8M | -$2.1M | -$2.9M | -$2.8M | -$1.4M | |||
| Research And Development Expense | $254.9K | $726.2K | $898.1K | $1.3M | $1.7M | $1.2M | $820.9K | $40.7K | $467.3K | $870.0K | $2.1M | $1.1M | $879.9K | $1.0M | $1.3M | $445.5K |
| Operating Income Loss | -$5.1M | -$3.6M | -$5.1M | -$6.3M | -$6.7M | -$3.3M | -$2.5M | -$2.1M | -$1.8M | -$2.1M | -$2.6M | -$2.4M | -$1.4M | -$2.1M | -$1.9M | -$881.7K |
| Operating Expenses | $5.1M | $3.6M | $5.1M | $6.3M | $6.7M | $3.3M | $2.5M | $2.1M | $1.8M | $2.1M | $2.8M | $2.4M | $1.4M | $2.1M | $1.9M | $881.7K |
| Investment Income Nonoperating | $7.4K | $7.0K | $17.5K | $11.2K | $626.00 | $4.3K | $49.7K | $4.9K | $1.4K | $183.00 | $78.00 | $66.00 | $3.00 | $8.00 | $125.00 | $1.4K |
| General And Administrative Expense | $4.9M | $2.8M | $4.2M | $2.5M | $3.0M | $765.1K | $1.7M | $2.1M | $1.3M | $1.3M | $754.4K | $1.3M | $495.0K | $1.1M | $533.4K | $436.1K |
| Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party | $765.1K | $422.6K | $833.6K | $83.7K | $182.3K | $99.9K | $784.6K | $115.8K | $724.2K | |||||||
| Interest Expense | $9.2K | $16.8K | $16.2K | $8.9K | $7.4K | $3.7K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Advances On Research And Development Contract Services | $78.0K | $147.0K | $150.2K | $76.9K | $183.5K | $207.7K | $231.2K | $33.9K | $51.6K | $29.0K | $10.1K | |||||
| Related Parties Research And Development Costs | $22.2K | $105.7K | $427.4K | $970.7K | $435.7K | $304.1K | $185.5K | |||||||||
| Research And Development Contract Liabilities Current | $232.1K | $235.1K | $157.1K | $165.0K | $77.0K | $15.8K | $15.7K | |||||||||
| Research And Development Contract Liabilities | $61.0K | $59.1K | $124.6K | $58.2K | $47.3K | $14.0K | $74.7K | $0.00 | ||||||||
| General And Administrative Stock Based Compensation Expenses | $1.5M | $2.2M | $580.6K | $314.6K | $785.6K | $38.7K | $109.3K | $157.7K | $775.1K | |||||||
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| General And Administrative Stock Based Expenses | $775.1K | $119.1K | $723.6K | $204.9K | ||||||||||||
| Research And Development Stock Based Expenses | $171.0K | $125.00 | $293.5K | $982.00 | ||||||||||||
| Research And Development Stock Based Compensation Expenses | $670.7K | $434.0K | $32.0K | $177.9K | $392.0K | $171.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.0M | -$775.7K | -$709.6K | -$986.0K | -$1.0M | -$971.3K | -$1.0M | -$1.7M | -$1.4M | -$1.5M | -$1.5M | -$1.7M | -$1.2M | -$1.7M | -$1.7M | -$1.6M | -$373.1K | -$383.2K | -$1.1M | -$610.5K | -$428.7K | -$1.0M | -$371.4K | -$379.2K | -$462.4K | -$292.8K | -$620.6K | -$646.9K | -$555.0K | -$416.5K | -$779.7K | -$500.7K | -$957.9K | -$501.4K | -$741.3K | -$928.8K | -$313.1K | -$368.8K | -$333.9K | -$2.0M | -$734.0K | -$591.9K | -$699.1K | -$347.8K | -$351.0K | -$378.0K | -$309.7K | ||
| Research And Development Expense | $50.7K | $60.6K | $91.5K | $361.6K | $210.7K | $119.1K | $132.5K | $427.5K | $189.1K | $272.4K | $164.8K | $458.5K | $227.2K | $262.4K | $443.5K | $799.4K | $117.9K | $94.7K | $570.6K | $80.1K | $48.3K | $3.5K | $41.1K | $25.7K | $205.7K | $14.6K | $143.2K | $336.0K | $316.9K | $264.5K | $624.4K | $287.0K | $505.5K | $309.1K | $335.7K | $162.8K | $219.9K | $248.8K | $166.3K | $393.7K | $217.3K | $273.6K | $364.4K | $224.2K | $261.4K | $132.7K | $233.1K | ||
| Operating Income Loss | -$1.8M | -$774.8K | -$706.9K | -$983.3K | -$1.0M | -$966.9K | -$1.0M | -$1.7M | -$1.4M | -$1.5M | -$1.5M | -$1.7M | -$1.2M | -$1.7M | -$1.7M | -$1.6M | -$373.4K | -$387.2K | -$1.1M | -$627.9K | -$438.7K | -$1.0M | -$371.9K | -$379.8K | -$463.2K | -$292.9K | -$602.6K | -$647.1K | -$555.0K | -$416.6K | -$779.7K | -$500.7K | -$752.2K | -$501.4K | -$517.3K | -$715.8K | -$313.1K | -$368.8K | -$333.9K | -$838.2K | -$400.0K | -$591.9K | -$499.2K | -$347.8K | -$351.1K | -$378.7K | -$310.0K | ||
| Operating Expenses | $1.8M | $774.8K | $706.9K | $983.3K | $1.0M | $966.9K | $1.0M | $1.7M | $1.4M | $1.5M | $1.5M | $1.7M | $1.2M | $1.7M | $1.7M | $1.6M | $373.4K | $387.2K | $1.1M | $627.9K | $438.7K | $1.0M | $371.9K | $379.8K | $463.2K | $292.9K | $620.6K | $647.1K | $555.0K | $416.6K | $779.7K | $500.7K | $752.2K | $501.4K | $517.3K | $715.8K | $313.1K | $368.8K | $333.9K | $838.2K | $400.0K | $591.9K | $499.2K | $347.8K | $351.1K | $378.7K | $310.0K | ||
| Investment Income Nonoperating | $4.4K | $365.00 | $441.00 | $1.4K | $2.2K | $2.9K | $5.8K | $2.7K | $5.0K | $3.9K | $191.00 | $109.00 | $161.00 | $180.00 | $146.00 | $38.00 | $264.00 | $4.0K | $13.9K | $17.4K | $10.0K | $424.00 | $525.00 | $599.00 | $797.00 | $152.00 | $12.00 | $141.00 | $21.00 | $11.00 | $25.00 | $35.00 | $11.00 | $27.00 | $28.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $5.00 | $27.00 | $37.00 | $47.00 | $700.00 | $333.00 | ||
| General And Administrative Expense | $1.8M | $714.2K | $615.5K | $621.6K | $798.4K | $847.8K | $356.0K | $522.6K | $519.5K | $644.0K | $753.5K | $565.9K | $573.5K | $1.5M | $816.0K | $802.3K | $255.4K | $292.5K | $522.4K | $547.8K | $390.4K | $1.0M | $330.8K | $354.1K | $257.5K | $278.4K | $477.4K | $311.1K | $238.1K | $152.1K | $155.3K | $213.7K | $246.6K | $192.3K | $181.6K | $553.0K | $93.2K | $120.0K | $167.6K | $444.5K | $182.8K | $318.3K | $134.9K | $123.6K | $89.6K | $246.0K | $76.9K | ||
| Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party | $541.0K | $1.0M | $816.0K | $464.5K | $27.0K | $27.0K | $32.0K | $323.7K | $39.9K | $784.4K | $12.0K | $12.0K | $12.0K | $13.8K | $15.8K | $22.2K | $119.7K | $18.3K | $6.3K | $6.3K | $81.2K | $82.1K | $62.8K | $386.9K | $14.7K | $38.9K | $47.3K | ||||||||||||||||||||||
| Interest Expense | $457.00 | $1.8K | $3.1K | $1.0K | $4.2K | $7.2K | $279.00 | $1.9K | $3.9K | $2.1K | $627.00 | $2.5K | $845.00 | $2.1K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Advances On Research And Development Contract Services | $78.0K | $78.0K | $78.0K | $131.2K | $147.0K | $147.0K | $147.0K | $216.0K | $323.3K | $13.0K | $29.8K | $43.4K | $2.2K | $192.2K | $197.2K | $200.4K | $217.3K | $232.3K | $175.5K | $29.5K | $35.0K | $28.9K | $36.2K | $42.3K | $66.1K | $33.8K | $46.1K | $29.0K | $34.0K | $63.4K | |||||||||||||||||||
| Related Parties Research And Development Costs | $17.4K | $33.9K | $804.00 | $0.00 | $40.2K | $0.00 | $64.6K | $130.8K | $93.3K | $116.6K | $162.4K | $155.1K | $353.0K | $85.4K | $95.0K | $85.5K | $92.0K | $79.0K | $62.4K | ||||||||||||||||||||||||||||||
| Research And Development Contract Liabilities Current | $235.2K | $256.1K | $242.6K | $256.1K | $290.1K | $216.1K | $90.6K | $36.1K | $26.4K | $100.9K | $158.8K | $275.1K | $26.7K | $213.9K | $93.5K | $61.9K | $24.1K | $64.4K | $94.3K | $35.8K | $39.2K | ||||||||||||||||||||||||||||
| Research And Development Contract Liabilities | $34.1K | $15.7K | $62.4K | $62.4K | $50.2K | $93.0K | $40.7K | $42.2K | $83.5K | $62.0K | $107.2K | $101.0K | $120.2K | $144.2K | $105.1K | $49.3K | $36.5K | $62.2K | $33.3K | $30.5K | $13.1K | $95.6K | $213.2K | $114.6K | $89.6K | ||||||||||||||||||||||||
| General And Administrative Stock Based Compensation Expenses | $277.0K | $339.7K | $656.0K | $12.9K | $3.8K | $81.7K | |||||||||||||||||||||||||||||||||||||||||||
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||
| General And Administrative Stock Based Expenses | $81.7K | $380.6K | $53.0K | $356.5K | $100.7K | $214.0K | $53.3K | $40.5K | |||||||||||||||||||||||||||||||||||||||||
| Research And Development Stock Based Expenses | $2.3K | $2.5K | $0.00 | $293.5K | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||||
| Research And Development Stock Based Compensation Expenses | $68.1K | -$30.4K | $2.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.7M | $827.2K | $4.0M | $5.2M | $4.8M | $5.0M | $2.4M | $4.1M | $995.0K | $214.8K | $312.3K | $265.9K | $236.3K | $1.5M | $0.00 | |||
| Liabilities Current | $1.3M | $318.3K | $313.9K | $395.8K | $302.9K | $216.5K | $237.9K | $210.9K | $373.0K | $218.7K | $285.6K | $273.4K | $321.8K | $261.2K | $350.7K | $195.1K | ||
| Liabilities And Stockholders Equity | $12.7M | $1.1M | $4.3M | $5.6M | $5.1M | $5.2M | $2.7M | $4.3M | $1.4M | $433.4K | $598.0K | $539.3K | $558.0K | $1.8M | $429.8K | $1.9M | ||
| Common Stock Value | $879.00 | $225.00 | $225.00 | $166.00 | $1.4K | $1.2K | $1.1K | $6.7K | $5.8K | $4.8K | $4.8K | $4.5K | $4.2K | $4.2K | $3.5K | $3.5K | ||
| Assets | $12.7M | $1.1M | $4.3M | $5.6M | $5.1M | $5.2M | $2.7M | $4.3M | $1.4M | $433.4K | $598.0K | $539.3K | $558.0K | $1.8M | $429.8K | $1.9M | ||
| Accounts Payable And Accrued Liabilities Current | $436.5K | $83.2K | $156.8K | $230.7K | $226.0K | $190.3K | $143.5K | $195.2K | $312.0K | $159.6K | $159.1K | $122.5K | $107.8K | $80.4K | $109.3K | $28.3K | ||
| Assets Current | $5.2M | $1.1M | $5.6M | $5.1M | $5.2M | $2.7M | $4.3M | $1.4M | $433.4K | $598.0K | $539.3K | $558.0K | $1.8M | $429.8K | $1.9M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $5.1M | $1.0M | $4.2M | $5.4M | $4.8M | $5.1M | $2.6M | $4.3M | $1.3M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $5.4M | $4.8M | $5.1M | $2.6M | $4.3M | $199.9K | $25.3K | $44.4K | $475.0K | $1.7M | ||||||||
| Preferred Stock Value | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $1.8M | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Prepaid Expense And Other Assets Current | $10.2K | $15.0K | $24.3K | $61.4K | $62.3K | $50.0K | $60.9K | $50.0K | $43.0K | $40.2K | $35.4K | $34.6K | ||||||
| Retained Earnings Accumulated Deficit | -$58.1M | -$52.1M | -$48.5M | -$43.4M | -$37.1M | -$30.4M | -$27.1M | -$24.6M | -$22.5M | -$20.7M | -$18.6M | -$15.7M | -$13.0M | |||||
| Cash | $5.4M | $4.8M | $5.1M | $2.6M | $4.3M | $199.9K | $25.3K | $44.4K | $475.0K | $1.7M | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | $3.0M | $1.1M | $174.6K | -$19.1K | -$430.6K | -$1.2M | $1.6M | -$104.8K | -$1.4M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.2M | -$1.1M | $529.6K | -$245.5K | $2.5M | -$1.7M | $3.0M | |||||||||||
| Liquidated Damages Payable Under Registration Rights Agreement | $74.0K | $74.0K | $74.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q4 2009 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.9M | $651.5K | $1.2M | $1.4M | $2.2M | $3.1M | $4.0M | $4.9M | $2.7M | $4.1M | $6.4M | $7.5M | $3.5M | $6.1M | $6.9M | $7.6M | $1.1M | $1.7M | $2.1M | $2.8M | $3.4M | $3.7M | -$14.1K | $244.5K | $615.9K | $1.4M | $1.8M | $666.1K | $738.0K | $1.2M | $1.0M | $804.9K | $1.3M | $1.4M | $593.9K | $975.0K | -$96.3K | $580.3K | $878.7K | $1.2M | $1.7M | $1.9M | -$265.6K | $79.0K | $638.1K | $1.1M | $1.7M | $1.3M | -$323.5K | $376.9K | $552.6K | -$14.6K | |||||
| Liabilities Current | $521.4K | $537.1K | $355.1K | $329.0K | $421.5K | $462.8K | $311.7K | $402.6K | $250.0K | $408.3K | $531.5K | $644.6K | $258.7K | $376.3K | $242.4K | $221.5K | $214.0K | $225.3K | $309.3K | $223.0K | $244.8K | $459.0K | $338.3K | $238.7K | $256.2K | $241.8K | $254.5K | $195.6K | $139.6K | $192.6K | $222.2K | $198.2K | $254.2K | $402.3K | $327.2K | $284.2K | $293.5K | $266.0K | $270.1K | $246.5K | $351.3K | $467.1K | $362.4K | $337.1K | |||||||||||||
| Liabilities And Stockholders Equity | $5.4M | $1.2M | $1.5M | $1.7M | $2.7M | $3.6M | $5.2M | $3.1M | $4.3M | $6.8M | $8.0M | $4.1M | $6.3M | $7.2M | $7.9M | $1.4M | $1.9M | $2.3M | $3.1M | $3.6M | $4.0M | $444.9K | $582.8K | $854.6K | $1.7M | $2.1M | $920.6K | $933.6K | $1.4M | $1.2M | $1.0M | $1.5M | $1.7M | $996.2K | $1.3M | $187.9K | $873.8K | $1.1M | $1.5M | $2.0M | $2.3M | $201.6K | $1.0M | $1.4M | |||||||||||||
| Common Stock Value | $570.00 | $276.00 | $268.00 | $225.00 | $225.00 | $225.00 | $225.00 | $166.00 | $1.7K | $1.7K | $1.7K | $1.4K | $1.4K | $1.4K | $1.4K | $6.7K | $6.7K | $6.7K | $6.7K | $6.7K | $6.7K | $5.8K | $5.8K | $5.8K | $5.8K | $5.8K | $5.2K | $4.8K | $4.8K | $4.8K | $4.8K | $4.7K | $4.6K | $4.5K | $4.5K | $4.2K | $4.2K | $4.2K | $4.2K | $4.2K | $4.1K | $3.5K | $3.5K | $3.5K | |||||||||||||
| Assets | $5.4M | $1.2M | $1.5M | $1.7M | $2.7M | $3.6M | $5.2M | $3.1M | $4.3M | $6.8M | $8.0M | $4.1M | $6.3M | $7.2M | $7.9M | $1.4M | $1.9M | $2.3M | $3.1M | $3.6M | $4.0M | $444.9K | $582.8K | $854.6K | $1.7M | $2.1M | $920.6K | $933.6K | $1.4M | $1.2M | $1.0M | $1.5M | $1.7M | $996.2K | $1.3M | $187.9K | $873.8K | $1.1M | $1.5M | $2.0M | $2.3M | $201.6K | $1.0M | $1.4M | |||||||||||||
| Accounts Payable And Accrued Liabilities Current | $235.9K | $92.1K | $112.5K | $72.9K | $131.4K | $246.7K | $221.2K | $366.5K | $223.6K | $307.4K | $372.7K | $369.5K | $232.0K | $162.4K | $148.9K | $115.5K | $189.9K | $160.9K | $273.5K | $183.9K | $210.7K | $396.6K | $275.9K | $188.5K | $163.2K | $201.1K | $212.2K | $112.1K | $77.5K | $83.4K | $121.2K | $78.0K | $110.0K | $130.5K | $111.1K | $81.0K | $64.6K | $66.0K | $72.9K | $66.7K | $89.1K | $87.2K | $81.1K | $80.8K | |||||||||||||
| Assets Current | $5.4M | $989.8K | $1.7M | $2.7M | $3.6M | $4.3M | $5.2M | $3.1M | $4.3M | $6.8M | $8.0M | $4.1M | $6.3M | $7.2M | $7.9M | $1.2M | $1.8M | $2.3M | $3.1M | $3.6M | $4.0M | $440.3K | $575.9K | $854.6K | $1.7M | $2.1M | $920.6K | $933.6K | $1.4M | $1.2M | $1.0M | $1.5M | $1.7M | $996.2K | $1.3M | $187.9K | $873.8K | $1.1M | $1.5M | $2.0M | $2.3M | $201.6K | $1.0M | $1.4M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.9M | $887.2K | $1.4M | $1.6M | $2.6M | $3.4M | $5.1M | $2.9M | $4.1M | $6.6M | $7.7M | $3.8M | $6.0M | $6.8M | $7.7M | $1.1M | $1.8M | $2.2M | $3.0M | $3.6M | $3.9M | $374.4K | $536.0K | ||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $3.4M | $4.2M | $5.1M | $2.9M | $4.1M | $6.6M | $7.7M | $3.8M | $6.0M | $6.8M | $7.7M | $1.1M | $1.8M | $2.2M | $3.0M | $3.6M | $3.9M | $374.4K | $536.0K | $808.0K | $1.3M | $1.6M | $2.0M | $870.9K | $669.8K | $95.8K | $99.4K | $217.6K | $126.5K | $140.1K | $8.9K | $46.7K | $115.4K | ||||||||||||||||||||||||
| Preferred Stock Value | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $1.8M | $1.8M | $1.8M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Prepaid Expense And Other Assets Current | $27.8K | $49.6K | $56.1K | $10.4K | $24.0K | $40.6K | $51.9K | $32.2K | $44.9K | $62.5K | $13.0K | $30.6K | $47.8K | $67.1K | $38.2K | $57.1K | $66.0K | $39.9K | $46.5K | $60.8K | $30.3K | $49.6K | $71.6K | $31.6K | $54.1K | $68.1K | $42.2K | $49.6K | $64.1K | $26.8K | $37.4K | $40.6K | $20.8K | $34.3K | $40.9K | $25.7K | $22.7K | $35.5K | $22.4K | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$55.5M | -$53.6M | -$52.8M | -$51.4M | -$50.5M | -$49.5M | -$47.4M | -$46.4M | -$44.8M | -$41.8M | -$40.3M | -$38.7M | -$35.1M | -$33.8M | -$32.1M | -$29.4M | -$27.8M | -$27.5M | -$26.8M | -$25.7M | -$25.1M | -$24.3M | -$23.3M | -$22.9M | -$22.1M | -$21.6M | -$21.3M | -$20.2M | -$19.5M | -$19.0M | -$18.0M | -$17.2M | -$16.7M | -$15.1M | -$14.6M | ||||||||||||||||||||||
| Cash | $3.4M | $4.2M | $5.1M | $2.9M | $4.1M | $6.6M | $7.7M | $3.8M | $6.0M | $6.8M | $7.7M | $1.1M | $1.8M | $2.2M | $3.0M | $3.6M | $3.9M | $374.4K | $536.0K | $808.0K | $1.3M | $1.6M | $2.0M | $870.9K | $669.8K | $95.8K | $99.4K | $217.6K | $126.5K | $140.1K | $8.9K | $46.7K | $115.4K | ||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$379.4K | -$497.7K | $671.0K | $95.7K | $95.7K | -$359.6K | -$280.5K | $54.4K | -$76.3K | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $345.7K | -$789.2K | -$1.3M | -$1.0M | $2.7M | -$414.0K | -$379.4K | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Liquidated Damages Payable Under Registration Rights Agreement | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2007 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $1.4M | $418.4K | $773.2K | $1.5M | $2.2M | $480.6K | $946.2K | $119.3K | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$3.1M | -$3.2M | -$4.3M | -$4.6M | -$4.1M | -$2.1M | $1.7M | -$1.5M | -$1.4M | -$1.7M | -$2.2M | -$1.6M | -$1.2M | -$1.2M | -$1.4M | -$936.4K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $380.8K | -$73.6K | -$74.0K | $2.3K | $35.7K | $46.7K | -$51.7K | -$116.8K | $152.4K | $519.00 | $36.5K | $14.8K | $27.4K | -$28.9K | $81.0K | -$55.2K | ||
| Increase Decrease In Research And Development Contract Liabilities | -$2.9K | $78.0K | -$7.9K | $88.1K | $61.2K | -$78.6K | $78.6K | -$45.3K | $1.9K | -$65.5K | $66.4K | $10.9K | $33.3K | -$60.7K | $74.7K | -$50.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $131.00 | -$4.8K | -$9.3K | -$4.9K | $1.4K | $12.3K | -$10.9K | $10.9K | $7.0K | $2.8K | $4.8K | $708.00 | $7.3K | |||||
| Net Cash Provided By Used In Financing Activities | $10.3M | $3.1M | $5.1M | $3.9M | $4.6M | $4.5M | $2.5M | $1.7M | $2.1M | $1.4M | $0.00 | $2.5M | $5.0K | $1.1M | ||||
| Increase Decrease In Advances On Research And Development Contract Services | -$78.0K | -$69.0K | -$3.2K | $73.3K | $76.9K | -$183.5K | -$24.2K | -$23.5K | $197.3K | -$17.7K | $22.6K | $18.9K | $5.1K | |||||
| Proceeds From Issuance Of Common Stock | $6.1M | $3.1M | $5.1M | $3.7M | $4.6M | $4.5M | $2.5M | $0.00 | $0.00 | $1.5K | ||||||||
| Proceeds From Stock Options Exercised | $6.3K | $201.0K | $3.0K | $18.0K | $0.00 | $33.3K | $0.00 | $33.3K | ||||||||||
| Stock Issued During Period Value Share Based Compensation | ||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$3.2M | $104.1K | $109.6K | -$207.6K | -$1.00 | $345.0K | $1.2M | -$1.6M | ||||||||||
| Payments To Acquire Money Market Funds | -$104.1K | -$109.6K | $207.6K | $1.00 | -$345.0K | -$1.2M | $1.6M | |||||||||||
| Proceeds From Warrant Exercises | $45.8K | $41.00 | $17.1K | $315.0K | $1.4M | $0.00 | $2.5M | |||||||||||
| Increase Decrease In Prepaid Insurance | $5.8K | $3.8K | -$32.1K | -$59.8K | $41.7K | $32.8K | $4.3K | |||||||||||
| Payments Of Stock Issuance Costs | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $0.00 | $0.00 | $1.1M | ||||||||||||||
| Proceeds From Issuance Of Notes Payable To Consultants | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Proceeds From Contributed Capital | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Payments To Acquire Machinery And Equipment | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q3 2019 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $106.8K | $130.7K | $102.9K | $112.1K | $280.1K | $277.0K | $396.9K | $424.1K | $339.7K | $347.2K | $656.0K | $464.5K | $32.0K | $84.0K | $383.2K | |||||||||
| Net Cash Provided By Used In Operating Activities | -$568.5K | -$789.2K | -$1.3M | -$1.0M | -$1.0M | -$414.0K | -$379.4K | -$497.7K | -$329.0K | -$325.9K | -$538.6K | -$359.6K | -$280.5K | -$249.0K | -$76.2K | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $56.8K | $89.9K | -$6.1K | $143.5K | -$41.4K | $17.4K | $15.5K | -$123.5K | $52.6K | -$75.7K | -$12.6K | -$26.7K | -$7.5K | -$22.1K | $72.3K | |||||||||
| Increase Decrease In Research And Development Contract Liabilities | $7.5K | $59.0K | -$138.7K | $198.1K | $77.8K | -$30.0K | $18.4K | -$10.8K | -$16.8K | -$17.4K | $86.0K | -$10.8K | $16.5K | $138.5K | $35.1K | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $45.7K | $41.7K | $47.5K | -$5.3K | -$6.7K | -$15.8K | -$362.00 | -$6.8K | -$401.00 | -$5.6K | -$5.9K | -$12.6K | -$12.4K | |||||||||||
| Net Cash Provided By Used In Financing Activities | $914.2K | $6.3K | -$10.9K | $3.7M | $1.0M | $1.2M | $1.7M | $0.00 | $33.3K | $0.00 | ||||||||||||||
| Increase Decrease In Advances On Research And Development Contract Services | -$15.8K | -$3.2K | -$63.9K | $43.4K | -$183.5K | -$7.3K | -$55.7K | -$5.0K | $14.5K | $62.00 | $12.5K | |||||||||||||
| Proceeds From Issuance Of Common Stock | $914.2K | $3.7M | $1.0M | $0.00 | $0.00 | |||||||||||||||||||
| Proceeds From Stock Options Exercised | $6.3K | $0.00 | $33.3K | $0.00 | ||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $383.2K | $53.0K | ||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$766.7K | -$1.1M | -$1.00 | $270.0K | -$47.00 | |||||||||||||||||||
| Payments To Acquire Money Market Funds | $766.7K | $1.1M | $1.00 | -$270.0K | $47.00 | |||||||||||||||||||
| Proceeds From Warrant Exercises | $17.1K | $0.00 | $0.00 | |||||||||||||||||||||
| Increase Decrease In Prepaid Insurance | -$3.8K | $5.7K | $6.0K | $21.1K | $8.0K | -$5.8K | ||||||||||||||||||
| Payments Of Stock Issuance Costs | $10.5K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Proceeds From Issuance Of Notes Payable To Consultants | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Proceeds From Contributed Capital | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Payments To Acquire Machinery And Equipment | $0.00 | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.26 | -$1.59 | -$2.66 | -$3.99 | -$0.50 | -$0.29 | -$0.22 | -$0.04 | -$0.03 | -$0.04 | -$0.06 | -$0.06 | -$0.03 | -$0.09 | -$0.06 | -$0.03 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.5M | 11.3M | 11.2M | 58.8M | 55.8M | 47.9M | 46.8M | 44.4M | 41.6M | 39.0M | 35.2M | ||||||
| Common Stock Shares Outstanding | 8.8M | 2.2M | 2.2M | 1.7M | 13.7M | 12.4M | 11.2M | 67.0M | 58.0M | 47.9M | 47.9M | 45.5M | 41.6M | 41.6M | 35.3M | 35.1M | 25.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 8.8M | 2.2M | 2.2M | 1.7M | 13.7M | 12.4M | 11.2M | 67.0M | 58.0M | 47.9M | 47.9M | 45.5M | 41.6M | 41.6M | 35.3M | 35.1M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 2.2M | 1.9M | 1.6M | 13.5M | |||||||||||||
| Earnings Per Share Basic | $-1.59 | $-2.66 | $-3.99 | $-0.50 | |||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.8M | 2.2M | 1.9M | 1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.33 | -$0.29 | -$0.29 | -$0.44 | -$0.45 | -$0.43 | -$0.49 | -$1.00 | -$0.82 | -$0.89 | -$0.95 | -$0.09 | -$0.13 | -$0.14 | -$0.14 | -$0.03 | -$0.03 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.01 | -$0.02 | -$0.01 | -$0.02 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | -$0.05 | -$0.02 | -$0.02 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.7M | 13.6M | 12.8M | 11.2M | 11.2M | 11.2M | 67.0M | 67.0M | 67.0M | 58.0M | 58.0M | 58.0M | 58.0M | 57.7M | 49.4M | 47.9M | 47.9M | 47.9M | 46.1M | 46.7M | 45.5M | 45.5M | 45.0M | 41.6M | 41.6M | 41.6M | 41.6M | 41.6M | 37.4M | 35.3M | 35.3M | |||||||||||||||||
| Common Stock Shares Outstanding | 5.7M | 2.8M | 2.7M | 2.2M | 2.2M | 2.2M | 2.2M | 1.7M | 16.7M | 16.6M | 16.6M | 13.7M | 13.7M | 13.7M | 13.5M | 67.0M | 67.0M | 67.0M | 67.0M | 67.0M | 67.0M | 58.0M | 58.0M | 58.0M | 58.0M | 57.9M | 51.9M | 47.9M | 47.9M | 47.9M | 47.9M | 46.9M | 45.6M | 45.5M | 45.5M | 41.6M | 41.6M | 41.6M | 41.6M | 41.6M | 41.4M | 35.4M | 35.3M | 35.3M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Issued | 5.7M | 2.8M | 2.7M | 2.2M | 2.2M | 2.2M | 2.2M | 1.7M | 16.7M | 16.6M | 16.6M | 13.7M | 13.7M | 13.7M | 13.5M | 67.0M | 67.0M | 67.0M | 67.0M | 67.0M | 67.0M | 58.0M | 58.0M | 58.0M | 58.0M | 57.9M | 51.9M | 47.9M | 47.9M | 47.9M | 47.9M | 46.9M | 45.6M | 45.5M | 45.5M | 41.6M | 41.6M | 41.6M | 41.6M | 41.6M | 41.4M | 35.4M | 35.3M | 35.3M | ||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 175.0K | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 6.2M | 2.7M | 2.5M | 2.2M | 2.2M | 2.2M | 2.1M | 1.7M | 1.7M | 1.7M | 1.6M | 13.7M | 13.7M | 13.6M | 12.8M | |||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.33 | $-0.29 | $-0.29 | $-0.44 | $-0.45 | $-0.43 | $-0.49 | $-1.00 | $-0.82 | $-0.89 | $-0.95 | $-0.12 | $-0.09 | $-0.13 | $-0.14 | |||||||||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 350.0K | 350.0K | 350.0K | 175.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 6.2M | 2.7M | 2.5M | 2.2M | 2.2M | 2.2M | 2.1M | 1.7M | 1.7M | 1.7M | 1.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $66.0M | $49.4M | $49.0M | $45.1M | $38.4M | $31.9M | $26.0M | $25.3M | $20.0M | $17.4M | $17.1M | $16.0M | $13.2M | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $418.4K | $773.2K | $1.5M | $2.6M | $1.2M | $748.7K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $45.8K | $6.3K | $201.0K | $3.0K | $18.0K | |||||||||||
| Fair Value Of Warrant Discount | $171.8K | $134.4K | $0.00 | $334.0K | ||||||||||||
| Prepaid Insurance | $26.7K | $20.9K | $17.1K | $49.2K | $109.0K | $67.3K | $34.5K | |||||||||
| Liquidated Damages Under Registration Rights Agreement | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$3.4K | $2.0K | -$3.4K | -$1.2K | $890.00 | |||||||||||
| Reverse Merger Costs | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Depreciation Nonproduction | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Money Market Funds At Carrying Value | $104.1K | $213.7K | $6.1K | $6.1K | $351.1K | $1.6M | ||||||||||
| Stock Issued During Period Value New Issues | $914.2K | $3.1M | $5.1M | $3.7M | $4.6M | $4.5M | ||||||||||
| Interest Paid Net | $9.2K | $16.8K | $16.2K | $8.9K | $7.4K | $3.7K | ||||||||||
| Other Cost And Expense Operating | $1.5M | $1.1M | $1.2M | $724.5K | ||||||||||||
| Fair Value Of Warrant Extension | $0.00 | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $57.9M | $54.2M | $50.4M | $49.3M | $49.2M | $49.1M | $48.9M | $45.6M | $45.3M | $44.7M | $44.3M | $38.7M | $37.6M | $37.2M | $36.2M | $27.1M | $26.0M | $26.0M | $26.0M | $25.6M | $25.3M | $20.8M | $20.0M | $20.0M | $20.0M | $19.9M | $18.5M | $17.4M | $17.3M | $17.1M | $17.0M | $16.7M | $16.3M | ||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $692.1K | $268.0K | $99.7K | $106.8K | $130.7K | $102.9K | $112.1K | $280.1K | $277.0K | $396.9K | $424.1K | $339.7K | $347.2K | $850.8K | $656.0K | $1.1M | $439.1K | $296.7K | $12.9K | $772.4K | -$30.4K | ||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $45.8K | $6.3K | $100.0K | $101.0K | $3.0K | $33.3K | |||||||||||||||||||||||||||||||||||||||||
| Fair Value Of Warrant Discount | $171.8K | $134.4K | $0.00 | $0.00 | $0.00 | $0.00 | $334.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Prepaid Insurance | $29.5K | $14.6K | $17.1K | $17.1K | $22.6K | $22.8K | $23.2K | $54.7K | $55.2K | $86.7K | $100.5K | $130.1K | $98.3K | $76.0K | $75.3K | $69.1K | |||||||||||||||||||||||||||||||
| Liquidated Damages Under Registration Rights Agreement | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $581.00 | $79.00 | -$3.2K | $158.00 | -$116.00 | -$109.00 | $877.00 | $1.3K | -$1.3K | $142.00 | -$181.00 | -$1.2K | $94.00 | -$11.00 | |||||||||||||||||||||||||||||||||
| Reverse Merger Costs | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Depreciation Nonproduction | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Money Market Funds At Carrying Value | $1.1M | $870.8K | $524.1K | $1.1M | $1.3M | $893.7K | $1.2M | $6.1K | $6.1K | $6.1K | $6.1K | $6.1K | $6.1K | $81.1K | $801.1K | $1.3M | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $1.3M | $914.2K | $3.1M | $5.1M | $3.7M | ||||||||||||||||||||||||||||||||||||||||||
| Interest Paid Net | $3.1K | $7.2K | $3.9K | $2.5K | $2.1K | ||||||||||||||||||||||||||||||||||||||||||
| Other Cost And Expense Operating | $293.2K | $428.5K | $446.9K | $357.7K | $380.0K | $344.2K | $291.0K | $269.3K | $314.7K | $300.0K | $300.9K | $345.5K | |||||||||||||||||||||||||||||||||||
| Fair Value Of Warrant Extension | $0.00 | $0.00 | $0.00 | $1.1M | $0.00 | $0.00 | $199.8K | $0.00 |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.